C Diff Treatment

C Diff Treatment

1301 bookmarks
Custom sorting
Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection
Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection
Based on a WTP threshold of $150,000, fidaxomicin and bezlotoxumab plus vancomycin were estimated to be more cost-effective for treating an episode of CDI and preventing further recurrence than standard of care vancomycin. The addition of bezlotoxumab to vancomycin and extended-pulsed fidaxomicin we …
·pubmed.ncbi.nlm.nih.gov·
Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection
In Crystallo Time-Resolved Interaction of the Clostridioides difficile CDD-1 enzyme with Avibactam Provides New Insights into the Catalytic Mechanism of Class D beta-lactamases
In Crystallo Time-Resolved Interaction of the Clostridioides difficile CDD-1 enzyme with Avibactam Provides New Insights into the Catalytic Mechanism of Class D beta-lactamases
Class D β-lactamases have risen to notoriety due to their wide spread in bacterial pathogens, propensity to inactivate clinically important β-lactam antibiotics, and ability to withstand inhibition by the majority of classical β-lactamase inhibitors. Understanding the catalytic mechanism of these en …
·pubmed.ncbi.nlm.nih.gov·
In Crystallo Time-Resolved Interaction of the Clostridioides difficile CDD-1 enzyme with Avibactam Provides New Insights into the Catalytic Mechanism of Class D beta-lactamases
Budget impact analysis of using procalcitonin to optimize antimicrobial treatment for patients with suspected sepsis in the intensive care unit and hospitalized lower respiratory tract infections in Argentina
Budget impact analysis of using procalcitonin to optimize antimicrobial treatment for patients with suspected sepsis in the intensive care unit and hospitalized lower respiratory tract infections in Argentina
Healthcare and financial benefits can be obtained by implementing procalcitonin-guided algorithms in Argentina. Although we found results to be robust on an aggregate level, some caution must be used when focusing only on sepsis patients in the intensive care unit.
·pubmed.ncbi.nlm.nih.gov·
Budget impact analysis of using procalcitonin to optimize antimicrobial treatment for patients with suspected sepsis in the intensive care unit and hospitalized lower respiratory tract infections in Argentina
Study Recommends Vancomycin as First-Line Treatment for Patients with C. Diff Infection and Inflammatory Bowel Disease - Pharmacy Times
Study Recommends Vancomycin as First-Line Treatment for Patients with C. Diff Infection and Inflammatory Bowel Disease - Pharmacy Times
Further, while there is ambiguity surrounding the treatment of IBD flare in patients with CDI, case reports suggest corticosteroid initiation after appropriate antibiotic therapy may be effective.
·pharmacytimes.com·
Study Recommends Vancomycin as First-Line Treatment for Patients with C. Diff Infection and Inflammatory Bowel Disease - Pharmacy Times
Advances in the Management of C difficile - Contagionlive.com
Advances in the Management of C difficile - Contagionlive.com
Experts discuss the bacteria’s transmission in the community setting, how to reduce disease and economic burdens, and ways to improve quality of life for patients.
·contagionlive.com·
Advances in the Management of C difficile - Contagionlive.com